Cytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART).
Skiest
D J
DJ
Department of Medicine, University of Texas Southwestern Medical Center, Dallas 75235-9113, USA. skiest@utsw.swmed.edu
D000998:Antiviral Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D000077404:Cidofovir; D017726:Cytomegalovirus Retinitis / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology / Q000473:pathology / Q000517:prevention & control; D003596:Cytosine / Q000031:analogs & derivatives / Q000627:therapeutic use; D003937:Diagnosis, Differential; D017245:Foscarnet / Q000627:therapeutic use; D015774:Ganciclovir / Q000627:therapeutic use; D006564:Herpesviridae / Q000145:classification; D006801:Humans; D015994:Incidence; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D012307:Risk Factors
D000998:Antiviral Agents; D015415:Biomarkers; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D017245:Foscarnet; D003596:Cytosine; D000077404:Cidofovir; D015774:Ganciclovir